Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who suffered from symptomatic COVID infection with rapid antigen test or RT PCR positive. 2. Patients within three months of resolution of acute COVID symptoms.
Exclusion criteria
Exclusion criteria: 1. Patients who cannot perform PFT analysis. 2. Patients who could not be assessed for anxiety disorders. (Intellectual disability, psychosis) 3. Patients with pre-existing known lung diseases such as Interstitial lung disease, COPD, Bronchiectasis etc. (Restrictive and obstructive lung disease) 4. Patients with pre-existing known anxiety disorders or depressive disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary objective 1. To determine the prevalence of anxiety disorders in patients who has restrictive and obstructive lung disease pattern after COVID-19 infection.Timepoint: Patients will be enrolled within 8 weeks of COVID-19 infection | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the factors associated with anxiety disorder such as depression, insomnia and ASD/PTSD in COVID recovered patients.Timepoint: 4 weeks;To assess the improvement in respiratory functions and anxiety levels after prescribing respiratory exercises.Timepoint: respiratory functions and anxiety levels reassessed in 4 weeks | — |
Countries
India
Contacts
All India Institute of Medical Sciences